ACHE and Alzheimer disease: Currently available therapies, such as NMDA receptor antagonists and acetylcholinesterase inhibitors, primarily treat neurodegenerative conditions, such as Alzheimer’s disease, rather than treating the disease itself (Shukla et al., 2024; Pardo-Moreno et al., 2022; Mathew et al., 2023).